Maria Joana Castelo-Branco de Assis Teixeira Neiva Correia is an Associate Professor at the College of Engineering, University of Lisbon, affiliated with the CERENA research unit. She teaches courses including Air Quality Engineering , Industrial Effluent Management , Introduction to Energy Systems , Biofuels , and Effluent Prevention and Treatment . Research Interests: Her work focuses on Sustainable energy systems and biofuels Biorefinery technologies Metal recovery from lithium-ion batteries Environmental engineering solutions for soil remediation and effluent treatment Process analytical technology (PAT) in biofuels manufacturing Catalytic processes for biodiesel production Scientific Activities: She has contributed to studies on solvent-based liquefaction of agricultural residues, heterogeneous catalyst screening for transesterification, and biosorption techniques for metal removal using materials like cork biomass and grape stalks. Labs/Teams: Affiliated with CERENA (Center for Environmental and Energy Research), a multidisciplinary research unit at Instituto Superior Técnico.
Pedro Nuno Sousa Sampaio is a faculty member at Universidade Lusófona, where he contributes to research and academic programs in biotechnology. His work bridges advanced spectroscopic methods with computational modeling for applications in food science, microbiology, and bioprocess engineering. Licenciatura in Biochemistry, Faculty of Sciences, University of Lisbon (1997) Mestrado in Biochemical Engineering - Biotechnology, Instituto Superior Técnico, University of Lisbon (2002) Doutoramento in Biotechnology, Instituto Superior Técnico, University of Lisbon (2009) Dr. Sampaio's research focuses on the integration of Fourier-transform infrared (FTIR) and near-infrared (NIR) spectroscopy with chemometrics and machine learning for rapid, non-destructive analysis of biological systems. His work spans bioprocess monitoring , food quality assessment , and biomarker discovery in pathogens like Helicobacter pylori . He has developed high-throughput methods for characterizing recombinant yeast strains, monitoring cyprosin production, and evaluating rice quality traits. The recent publications highlight a strong trend toward machine learning-enhanced spectroscopic analysis , particularly in food and microbial systems. His work increasingly leverages artificial neural networks, PLS-DA, SVM, and other algorithms to extract meaningful patterns from complex spectral data, enabling rapid classification and prediction in areas ranging from rice flour authentication to antimicrobial screening. Dr. Sampaio holds a patent on a pharmaceutical composition containing cyprosin B for anti-tumor formulations and contributed to the development of Cynzime®, an FDA GRAS-licensed milk-clotting enzyme derived from Cynara cardunculus . Pharmaceutical composition containing the enzyme cyprosin B for anti-tumorals (WO 2009/040778 A) Enzymatic additive Cynzime® licensed by FDA as GRAS He has collaborated with at least 13 coauthors in scientific publications and has contributed to the development of predictive models for rice quality, bioprocess monitoring tools, and datasets for spectroscopic analysis. His research supports sustainable biotechnological applications, including resource efficiency and circular economy principles. Dr. Sampaio has developed and applied high-throughput FT-MIR and NIR-based techniques for metabolic profiling in Escherichia coli and Saccharomyces cerevisiae cultures. These methods support rapid, economic, and scalable bioprocess analysis, contributing to advancements in biopharmaceutical production and recombinant protein optimization.
Prof. Dr. Michael Zavrel is a W3 Professor of Bioprocess Engineering at the Technical University of Munich’s TUM Campus Straubing for Biotechnology and Sustainability. He leads the Professorship Bioprocess Engineering, focusing on developing sustainable bioprocesses using non-food biogenic raw materials such as agricultural residues and waste streams. His research spans fermentation, downstream processing, and process design, emphasizing bio-based and biodegradable products. Education and Career: Zavrel earned his diploma and doctorate in Chemical Engineering from TUM and RWTH Aachen University, respectively. Before his academic role, he spent 14 years in industrial R&D at Süd-Chemie and Clariant, holding roles like Head of Development & Biomanufacturing and Site Manager. He joined TUM in 2022. Research Interests: His work addresses sustainable bioprocess development, including enzyme immobilization, soft sensor technology for bioprocess monitoring, and optimizing biorefinery systems. Key areas include fermentation optimization, bio-based material production, and process phase-dependent controls. Awards: Honors include the Borchers Plaque (RWTH Aachen, 2010), Jürgen Manchot Prize (TUM, 2006), and participation in the 2006 Lindau Nobel Laureate Meeting. In 2024, he won the Study Awards. Lab and Collaborations: His team works on industrial bioprocess challenges, collaborating with companies like Clariant. Research themes include aroma preservation in beverages, biomass hydrolysis, and PAT (Process Analytical Technology) for sustainable enzyme production.
Walkiria Schlindwein is Professor of Pharmaceutics at the Leicester School of Pharmacy, De Montfort University, within the Faculty of Health and Life Sciences. Her work bridges academic research and industrial application in pharmaceutical development, with strong collaborations with AstraZeneca, GlaxoSmithKline, MHRA, and others. Education: Chemical Engineering, Federal University of Rio de Janeiro (UFRJ), Brazil (1984) M.Sc. in Polymer Science and Technology, Institute of Macromolecules, UFRJ (1986) PhD in Chemistry, University of Leicester, UK (1990) DSc in Chemistry, UFRJ (1992) Her research focuses on pharmaceutical materials science , particularly polymer-based formulations, amorphous solid dispersions , and hot melt extrusion for enhancing drug solubility. She is a pioneer in Pharmaceutical Quality by Design (QbD) education, having led the development of the first MSc in Pharmaceutical Quality by Design in the UK. Her expertise extends to Process Analytical Technology (PAT) using in-line UV-Vis spectroscopy for real-time process monitoring and control. The recent articles demonstrate a consistent focus on continuous manufacturing, real-time process monitoring, and QbD-driven optimization of extrusion processes, particularly for poorly soluble drugs like itraconazole and ibuprofen. These works highlight a strong trend toward integrating advanced analytical tools with machine learning and predictive modeling in pharmaceutical development. Professional Memberships: Member, CMAC Advisory Board, University of Strathclyde Member, Academy of Pharmaceutical Sciences and Regulatory Focus Group Member, International Society of Pharmaceutical Engineering (ISPE) and Modelling Focus Group She actively supervises PhD students and leads multiple funded research projects. Her consultancy with companies such as RB and Kindeva reflects her impact on industrial pharmaceutical development. She is also involved in organizing key events like the Tabletting School 2025. Laboratory and Research Team: She leads research within the Pharmaceutical Technologies group at the Leicester Institute for Pharmaceutical Health and Social Care Innovations, focusing on innovative formulation strategies and process optimization for next-generation drug products.
Gerald Striedner serves as Professor and Head of the Institute of Bioprocess Science and Engineering at the University of Natural Resources and Life Sciences, Vienna (BOKU). He leads a comprehensive research group focused on upstream process development for the production of recombinant proteins, plasmid DNA, and virus-like particles using bacterial, insect, and mammalian cell systems. His research interests span advanced process characterization , E. coli expression system design , rational bioprocess development , process monitoring and control , continuous biomanufacturing , and synthetic biology applications . His work integrates PAT/QbD concepts to create efficient production platforms for bio-pharmaceutical, industrial, and environmental applications. Analysis of his recent publications reveals a strong focus on cutting-edge bioprocess technologies including non-canonical amino acid incorporation, advanced protein purification methods, continuous manufacturing platforms, and enzyme engineering for polymer degradation. His research demonstrates a consistent emphasis on both fundamental process understanding and practical applications for industrial biotechnology. As an academic leader, Professor Striedner supervises a diverse team including PhD students, postdocs, and senior scientists. His research group maintains active collaborations with academic partners across Europe, including institutions in Austria, Portugal, and Germany, reflecting the international scope of his work. His laboratory operates within BOKU's Institute of Bioprocess Science and Engineering, which features advanced pilot plant facilities for training and research purposes, providing an integrated environment for both fundamental research and practical application development in bioprocess engineering.
Will Crichton is an Assistant Professor of Computer Science at Brown University, where he leads the Cognitive Engineering Lab. His academic journey includes a PhD from Stanford University (2022) advised by Pat Hanrahan and Maneesh Agrawala, and a BS from Carnegie Mellon University (2016). Prior to his current position, he completed a postdoc at Brown with Shriram Krishnamurthi. PhD, Stanford University (2022) BS, Carnegie Mellon University (2016) Crichton's research uniquely bridges programming language theory and cognitive psychology, focusing on making programming more usable, learnable, and powerful. His work spans three interconnected domains: cognitive theories of computational abstractions, technical foundations of technical communication, and radical teaching tools. He develops systems like program slicers (Flowistry), document languages (Nota), and type system visualizers (Aquascope), with his Rust research having been adopted by over 100,000 developers worldwide. His publication record reveals a consistent focus on the intersection of programming languages and human factors. Recent work shows increasing emphasis on Rust programming language tools (2022-2025), document representation systems (2021-2024), and educational methodologies for programming language learning (2023-2024), demonstrating how theoretical programming language concepts can be made practically accessible to developers. Distinguished Paper award for Profiling Programming Language Learning (OOPSLA 2024) SIGPLAN Research Highlight for A Grounded Conceptual Model for Ownership Types in Rust (OOPSLA 2023) Crichton actively contributes to the Rust ecosystem through tools like Flowistry (a program slicer for Rust) and an experimental Rust textbook. His teaching philosophy emphasizes grounded approaches to programming language education, as evidenced by his work on the Rust Book Experiment. He has presented his research at venues including Jane Street (2025), P99 CONF (2024), and IWACO (2024), demonstrating practical applications of his theoretical work. At Brown University, Crichton's Cognitive Engineering Lab serves as the hub for his research on how cognitive principles can inform programming language design and implementation. The lab develops tools that help programmers understand complex systems through visualizations and interactive interfaces, with particular focus on Rust's ownership model and document representation systems.
Dr. Jyrki Tapio Heinämäki is a Professor of Pharmaceutical Nanotechnology and Program Director of the doctoral program in pharmacy at the University of Tartu , Institute of Pharmacy. He holds a permanent honorary Visiting Professor position at the University of Havana, Cuba, since 2008. His academic career spans institutions in Finland and Estonia, with appointments including Associate Professor at the University of Helsinki (1995) and a five-year term as Professor of Medical Technology at the University of Tartu (2010–2015). Dr. Heinämäki's research focuses on pharmaceutical nanotechnology and oral solid dosage forms , particularly powder technology , nanofiber fabrication , granulation , tableting , polymer coatings , and surface treatment of solid drug substances . His group develops nanotechnology-based solutions for improving solubility of poorly water-soluble drugs, multifunctional nanofibrous drugs for wound healing, electrospinning techniques , printed nanomaterial substrates for personalized pharmacotherapy, and formulations for natural products . They also advance Process Analytical Technologies (PAT) for pharmaceutical nanotechnology. With over 125 peer-reviewed articles (category 1.1) and 25 conference abstracts , Dr. Heinämäki has supervised or co-supervised 20 doctoral theses . His work bridges academic research and industrial pharmacy, including consultancy on drug marketing authorization applications. Formal details of his CV and publications are available via the Estonian Research Information System (ETIS).
Professor Maths Halstensen is a distinguished faculty member in the Department of Electrical Engineering, Information Technology and Cybernetics at the University of South-Eastern Norway (USN), Faculty of Technology, Natural Sciences and Maritime Sciences, Campus Porsgrunn. With a career spanning over two decades since his 2002 PhD, he has established himself as a leading expert in chemometrics and process analytical technology, maintaining continuous research output through 2019 with significant contributions to industrial monitoring systems. His academic journey includes: PhD in Acoustic Chemometrics from NTNU (2002) MSc in Process Automation from Telemark University College (1997) BSc in Industrial Electronics from Gjøvik University College (1995) Professor Halstensen's research program centers on developing multivariate data analysis techniques for industrial process monitoring, with particular emphasis on: Acoustic chemometrics for multiphase flow characterization CO2 capture process optimization using spectroscopic methods Real-time monitoring of scale deposition in pipelines Multivariate regression modeling for energy and process prediction Raman and NIR spectroscopy applications in industrial settings His work bridges theoretical chemometrics with practical industrial implementations, focusing on solutions for metallurgy, chemical processing, and carbon capture sectors. Analysis of his 15 most recent publications reveals a dominant focus on carbon capture technologies (60% of recent work), particularly equilibrium measurements in ammonia-CO2 systems and real-time monitoring of absorption processes. His research demonstrates consistent application of multivariate modeling to solve industrial challenges, with strong emphasis on sensor development and practical implementation. Key methodological contributions include acoustic chemometric approaches for velocity measurement and novel calibration techniques for complex industrial mixtures. As leader of the ACRG Laboratory, Professor Halstensen directs research in: Acoustic sensor development for industrial environments Spectroscopic monitoring system integration Multivariate data analysis for process optimization Real-time control system implementation His teaching encompasses BSc, MSc, and PhD levels with focus on practical engineering skills. The research group benefits from institutional support through USN's strategic focus on 'Energy, climate and the environment,' with likely connections to Research Council of Norway funding and EU research programs. Professor Halstensen maintains active industry collaborations through his applied research on process monitoring solutions for energy-intensive industries.
Jukka Rantanen serves as Professor and Head of the Department of Pharmacy within the Faculty of Health and Medical Sciences at the University of Copenhagen. Since joining the faculty in 2006 after postdoctoral training at Purdue University, he has established leadership roles including Chairman of the EUFEPS QbD and PAT Sciences Network Steering Committee and membership in the European Pharmacopoeia Commission's Process Analytical Technology Working Party. Education: Docent in Physical Pharmacy, University of Helsinki (2001) PhD in Pharmacy, University of Helsinki (2001) Research Focus: Professor Rantanen pioneers Process Analytical Technology (PAT) and innovative pharmaceutical manufacturing , with expertise spanning solid-state chemistry , crystallization science , and data-driven drug production . His work bridges additive manufacturing (3D printing of combination drugs), blockchain security for medications , and advanced granulation processes , driving industry adoption of Quality by Design principles. Research Trends: Recent publications (2023-2025) demonstrate intensified focus on computational approaches (CSD data mining for hydrate prediction), personalized medicine stability challenges, and manufacturing robustness. His team actively develops blockchain-based authentication systems while optimizing twin-screw granulation parameters for commercial-scale production. Scientific Recognition: APV Research Award for Outstanding Achievements in Pharmaceutical Sciences (2016) Academic Leadership: With supervision of 40+ PhD students and editorial roles at leading pharmaceutical journals, Rantanen shapes next-generation scientists. His research attracts significant industry funding through collaborations with 20+ international companies, particularly in solid-state chemistry consulting and litigation support. Former service on Denmark's Council for Independent Research (2013-2018) highlights policy influence. Research Infrastructure: Leads a multidisciplinary team at Copenhagen investigating real-time process monitoring, crystallization control, and 3D-printed drug products. Current projects include EUFEPS network initiatives advancing PAT implementation across European pharmaceutical manufacturing facilities.
Sandra Lenihan is a Lecturer in Chemical and Biopharmaceutical Engineering at Munster Technological University (MTU), where she has been faculty since 2009. She leads the Process innovation Engineering Research Group (PiERG) and serves as a Principal Investigator with the Pharmaceutical Manufacturing Technology Centre (PMTC) hosted at University of Limerick. Dr. Lenihan has established herself as a key researcher in pharmaceutical process engineering with strong industry connections. Her research focuses on developing predictive modeling for solid dosage pharmaceutical processes, particularly powder modeling for tablet processing and continuous manufacturing. She specializes in computational approaches using tools like Dynochem and finite element analysis to model unit operations including mixing, bioreactors, and filtration. Her work bridges academic research with industrial applications, resulting in numerous collaborations with pharmaceutical companies. Pharma Awards, Partnership Alliance WINNER (2018) Bridge Network Nomination for Invention of the Year (2018) Pharma Awards, 2nd Place: Education and Training Category (2020) Educational Awards, Best Student Experience Category Finalist (2020) Educational Awards, Career Impact Category Finalist (2020) Pharma Awards, Education and Training Category Finalist (2017) Dr. Lenihan supervises Capstone Final Engineering Research and Design Projects and has been instrumental in developing industry-academic partnerships. She previously served as Placement Manager for the Chemical Engineering Programme (2012-2020) and has secured significant funding through Springboard programs and Enterprise Ireland projects. Her teaching includes Process Engineering, Biopharmaceutical Engineering, and Pharmaceutical Applications, where she integrates practical industry experience with academic theory. She leads the PiERG research group, which provides solutions to the Pharma Engineering sector through expertise in predictive modeling and industrial pharma processing. Her current research includes an Enterprise Ireland IPP project in Tabletting and Coating (2022-2024) involving two postdocs working with Dr. Alexander Krok.
Holger Grohganz is an Associate Professor in the Department of Pharmacy at the Faculty of Pharmaceutical Sciences, University of Copenhagen, holding this position since May 2011. His academic journey spans multiple Nordic institutions, including prior appointments at Nord-Trøndelag University College and the University of Tromsø. His educational background includes: Ph.D. in Pharmacy, University of Tromsø (2004) Pharmacy degree, University of Erlangen-Nürnberg (1997) Registration as pharmacist (1998) Dr. Grohganz's research centers on stabilizing unstable pharmaceutical compounds, addressing critical challenges in drug development: structural instability of macromolecules and poor water solubility of small molecules. His work pioneers co-amorphous systems to enhance drug solubility while maintaining stability, alongside advancing freeze-drying techniques for protein therapeutics. Key methodologies include multivariate analysis and design of experiments for pharmaceutical process optimization. Co-amorphous drug formulations Freeze-drying and spray-drying of biologics Design of experiments (DoE) implementation Process analytical technology (PAT) His 2024-2025 publications reveal intensive focus on co-amorphous system stability under mechanical stress, crystallization mechanisms in hydrated systems, and novel electrospinning applications for drug delivery. Recent work extends to microfluidic liposome fabrication and inflammatory skin disease therapies using sustained-release dressings. Dr. Grohganz actively supervises Master's theses in Pharmacy and teaches core courses including 'Pharmacy 2 - Solid Dosage Forms' and 'Bachelor Project in Pharmacy,' emphasizing production, composition, and quality assurance of tablets and solid formulations. He leads research within the Solid State Pharmaceutics group at the University of Copenhagen, collaborating internationally on pharmaceutical development projects with emphasis on quality-by-design principles and advanced material characterization.
Professor Denise Salzig is a leading academic at the Technical University of Central Hesse, serving as Professor of Process Analytics in Bioprocess Engineering and Pharmaceutical Processes since 2022. She holds multiple leadership positions including Head of the Cell Culture Technology Department (since 2009), Director of the B.Sc. Biotechnology/Biopharmaceutical Technology program (since 2023), and member of the Doctoral Centre for Engineering Sciences at FCMH (since 2024). Her research encompasses cutting-edge work in: Bioprocess development for mammalian/human cell systems Process Analytical Technology (PAT) implementation Quality-by-Design frameworks for Advanced Therapy Medicinal Products Insect cell-based protein production Bioprocess scaling and computational simulations Professor Salzig actively oversees doctoral candidates in biotechnology and pharmaceuticals through the PZI doctoral center, emphasizing translational research with industrial applications in drug development and biomanufacturing.
